Prospective Quantitative Imaging Study by Magnetisation Transfer for Appearance of Perilesional Gliosis in Solitary Cerebral Cysticercal Lesion

Abstract

This study aimed to detect perilesional gliosis around solitary cerebral cysticerci (SCC) by magnetisation transfer imaging (MTI), to compare its incidence between patients administered and not administered albendazole. We prospectively randomised patients with SCC and new-onset seizures to treatment with albendazole plus antiepileptics (treatment), or antiepileptics only (control), and performed MRI scans at zero, three, six, 12 and 24 months. Data were analysed for lesion characteristics, perilesional MT hyperintensity and MT ratios, calculated from the lesion and perilesional area. Eighty-one patients' data were analysed (M-41, F-40; ages 6–52 years). About 13% scolices appeared hyperintense on MTI at baseline. T1-isointense cyst walls and perilesional area showed MT hyperintensity in 30 – 41.4%; this proportion increased over time. Persistently visible SCC and stage of degeneration at enrolment did not predict development of MT hyperintensity. MT ratios (range - 98.75 to 49.79) increased over time and differed significantly from normal parenchyma. No difference in MT ratios was noted between treatment and control groups. Qualitative perilesional MT hyperintensity was more often seen in control group. Perilesional gliosis is present in >20% of SCC at six months, and continues to appear on later scans. Gliosis is independent of lesion persistence and stage of degeneration. Pre- and post-contrast MT imaging is equally useful in detection of gliosis. MT ratios from the lesion and perilesional parenchyma are significantly lower than from normal brain tissue at all stages of degeneration, but increase as degeneration occurs and healing progresses. Albendazole therapy does not affect the formation of perilesional gliosis

Keywords

solitary cerebral cysticercal lesion neurocysticercosis perilesional gliosis magnetic resonance imaging magnetisation transfer imaging

Get full access to this article

View all access options for this article.

References

Bhigjee

Rosemberg

. Optimizing therapy of seizures in patients with HIV and cysticercosis. Neurology. 2006; 67 (12 Suppl 4): S19–S22.

Chatterjee

. Parasitology protozoology and helminthology. Calcutta: Guha Ray; 1973.

Hagen

Ahlhelm

Reiche

. Apparent diffusion coefficient in vasogenic edema and reactive astrogliosis. Neuroradiology. 2007; 49 (11): 921–926.

Pradhan

Kathuria

Gupta

. Perilesional gliosis and seizure outcome: A study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Ann Neurol. 2000; 48 (2): 181–187.

Gupta

Kathuria

Pradhan

. Magnetisation transfer magnetic resonance imaging demonstration of perilesional gliosis-relation with epilepsy in treated or healed neurocysticercosis. Lancet. 354 (9172): 44–45.

Bagley

Grossman

McGowan

. Magnetization transfer contrast: Its utility as a technique and its application to central nervous system pathology. Neurology. 1999; 53 (5 Suppl 3): S49–S51.

Gupta

Kathuria

Pradhan

. Magnetization transfer MR imaging demonstration of presumed perilesional gliosis around a healed / healing neurocysticercosis and its relationship with epilepsy. wwwcdsismrmorg 2000 January 22; Available at: URL: www.cds.ismrm.org/ismrm-2000.

Kramer

Locke

Byrd

. Cerebral cysticercosis: Documentation of natural history with CT. Radiology. 1989; 171 (2): 459–462.

Carpio

Santillan

Leon

. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med. 1995; 155 (18): 1982–1988.

10.

Del Brutto

Wadia

Dumas

. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 1996; 142 (1–2): 1–6.

11.

Rajshekhar

Haran

Prakash

. Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy. Clinical and computerized tomographic criteria. J Neurosurg. 1993; 78 (3): 402–407.

12.

Rajshekhar

Chandy

. Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol Scand. 1997; 96 (2): 76–81.

13.

Dumas

Visy

Belin

. Parenchymal neurocysticercosis: Follow-up and staging by MRI. Neuroradiology. 1997; 39 (1): 12–18.

14.

Salzman

. L. Neurocysticercosis. In: Osborn

, ed. Diagnostic Imaging (Brain). Amirsys, Inc.; 2004. p. 50–53.

15.

Teitelbaum

Otto

Lin

. MR imaging of neurocysticercosis. Am J Roentgenol. 1989; 153 (4): 857–866.

16.

McGowan

. The physical basis of magnetization transfer imaging. Neurology. 1999; 53 (5 Suppl 3): S3–S7.

17.

Kathuria

Gupta

Roy

. Measurement of magnetization transfer in different stages of neurocysticercosis. J Magn Reson Imaging. 1998; 8 (2): 473–479.

18.

Zee

Segall

Boswell

. MR imaging of neurocysticercosis. J Comput Assist Tomogr. 1988; 12 (6): 927–934.

19.

Agarwal

Raghav

Husain

. Epilepsy with focal cerebral calcification: Role of magnetization transfer MR imaging. Neurol India. 2004; 52 (2): 197–199.

20.

Kumar

Gupta

Rathore

. Multiparametric quantitation of the perilesional region in patients with healed or healing solitary cysticercus granuloma. Neuroimage. 2002; 15 (4): 1015–1020.

21.

Kimura

Meaney

McGowan

. Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: Characterization by magnetization transfer ratio with histopathologic correlation. J Comput Assist Tomogr. 1996; 20 (4): 540–546.

22.

Chung

Lee

Chi

. Temporal lobe epilepsy caused by intrahippocampal calcified cysticercus: A case report. J Korean Med Sci. 1998; 13 (4): 445–448.

23.

de Aluja

Villalobos

Plancarte

. Experimental Taenia solium cysticercosis in pigs: Characteristics of the infection and antibody response. Vet Parasitol. 1996; 61 (1–2): 49–59.

24.

Meyer

Androux

Salamon

. Contrast-enhanced magnetization transfer MR of the brain: Importance of precontrast images. Am J Neuroradiol. 1997; 18 (8): 1515–1521.

25.

Chawla

Husain

Kumar

. Correlative MR imaging and histopathology in porcine neurocysticercosis. J Magn Reson Imaging. 2004; 20 (2): 208–125.

26.

Sinson

Bagley

Cecil

. Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: Correlation with clinical outcome after traumatic brain injury. Am J Neuroradiol. 2001; 22 (1): 143–151.

27.

Silver

Barker

MacManus

. Magnetisation transfer ratio of normal brain white matter: A normative database spanning four decades of life. J Neurol Neurosurg Psychiatry. 1997; 62 (3): 223–228.

28.

Kumar

Gupta

Rao

. Magnetization transfer and T2 quantitation in normal appearing cortical gray matter and white matter adjacent to focal abnormality in patients with traumatic brain injury. Magn Reson Imaging. 2003; 21 (8): 893–899.

29.

Gupta

Kathuria

Pradhan

. Magnetization transfer MR imaging in CNS tuberculosis. Am J Neuroradiol. 1999; 20 (5): 867–875.

30.

Filippi

Rocca

. Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics. 2007; 4 (3): 401–413.

31.

Filippi

Rocca

. Magnetization transfer magnetic resonance imaging in the assessment of neurological diseases. J Neuroimaging. 2004; 14 (4): 303–313.

32.

Symms

Jager

Schmierer

. A review of structural magnetic resonance neuroimaging. J Neurol Neurosurg Psychiatry. 2004; 75 (9): 1235–1244.

33.

Lorenzo

Parisi

Cascino

. Intractable frontal lobe epilepsy: Pathological and MRI features. Epilepsy Res. 1995; 20 (2): 171–178.

34.

Del Brutto

, The use of albendazole in patients with single lesions enhanced on contrast CT. N Engl J Med. 1993 4; 328 (5): 356–357.

35.

de Souza

Nalini

Kovoor

. Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution. J Neurol Sci. 2010; 288 (1–2): 135–141.

36.

de Souza

Thennarasu

Yeshraj

. Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: Effect on long-term seizure outcome. J Neurol Sci. 2009; 276(1–2): 108–114.